Reitan Colleen F - Insider Transactions
Insider Type
individual
Companies
2
Average
9,721,327
Total Txns
20
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2024 | 2 | 1 | 1 | 10,362.68 | 1,285,851.35 | -1,275,488.67 |
| 2025 | 0 | 17 | -17 | 0.00 | 8,425,112.60 | -8,425,112.60 |
| Total: | 2 | 18 | 10 | 10,362.68 | 9,710,963.95 | -9,700,601.27 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
461.92 USD |
2,290 Sold |
1,057,797 USD |
09/09/2025 | 09/09/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
463.00 USD |
1,652 Sold |
764,876 USD |
09/09/2025 | 09/09/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
464.36 USD |
799 Sold |
371,024 USD |
09/09/2025 | 09/09/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
460.71 USD |
473 Sold |
217,916 USD |
09/09/2025 | 09/09/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
458.86 USD |
1,888 Sold |
866,328 USD |
09/09/2025 | 09/09/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
457.44 USD |
1,645 Sold |
752,489 USD |
09/09/2025 | 09/09/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
474.22 USD |
838 Sold |
397,396 USD |
09/09/2025 | 09/09/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
472.82 USD |
823 Sold |
389,131 USD |
09/09/2025 | 09/09/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
471.25 USD |
222 Sold |
104,618 USD |
09/09/2025 | 09/09/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
459.73 USD |
1,403 Sold |
645,001 USD |
09/09/2025 | 09/09/2025 |